Celgene Corp. buy tamam
Start price
24.08.15
/
50%
€102.94
Target price
28.08.15
€117.40
Performance (%)
7.65%
End price
28.08.15
€110.81
Summary
This prediction ended on 28.08.15 with a price of €110.81. The BUY prediction by tamam finished with a performance of 7.65%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1,66 % | -10,87 % | -0,72 % | 41,87 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % | 13,41 % | 70,29 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % | 25,46 % | 45,96 % |
| iShares S&P 500 | -2,30 % | -4,80 % | 8,94 % | 54,18 % |
Comments by tamam for this prediction
In the thread Celgene Corp. diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 24.08.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 130.16€ zu.
(Vom Mitglied beendet)